Case report · 10 Apr 2023
EditorialPublished 2014
Approval for Novel Drugs in Chronic Lymphocytic Leukemia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chronic lymphocytic leukemia (CLL) is a mature B-cell lymphoid neoplasm characterized by the proliferation and accumulation of small CD5/CD19/CD23-positive lymphocytes in the blood, lymph nodes, spleen, liver and bone marrow. It is the most prevalent leukemia in the western world with an estimated 15,720 new cases in 2014 and almost 4600 attributable deaths per year in the United States. CLL is typically sensitive to a variety of cytotoxic drugs, but the disease is considered incurable. Cytotoxic agents, including chlorambucil, bendamustin and purine analogs, currently constitute the basis of the most frequently used therapeutic regimens. In addition, anti- CD20 monoclonal antibodies (mAbs), rituximab and ofatumumab, and the anti-CD52 antibody alemtuzumab, alone or in combination with cytotoxic drugs, have been included for therapeutic options in this leukemia.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 18 Jul 2016
QRT-AAGEL-Quantitative Real Time PCR Analysis of Apoptotic Gene Expression In Chronic Lymphocytic Leukemia Patients and Their Relationships With Chemosensitivity
Case report · 15 May 2016
Rapid transformation of chronic lymphocytic leukemia to acute lymphoblastic leukemia: A rare case report
Opinion · 30 Aug 2022
Optimal Exposure of Fludarabine in Patients with Chronic Lymphocytic Leukemia
Conference abstract
New biodegradable nanoparticle systems for the treatment of chronic lymphocytic Leukemia and lymphomas
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tadeusz Robak”

